Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (8)
P 1 (2)
P 2 (4)
P 3 (3)

Trial Status

Completed9
Not Yet Recruiting4
Unknown4
Withdrawn2
Suspended1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT03568019Active Not RecruitingPrimary

PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors

NCT07533227Phase 2Not Yet RecruitingPrimary

Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia

NCT07519564Phase 1Not Yet RecruitingPrimary

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

NCT07185308Not ApplicableNot Yet RecruitingPrimary

Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer

NCT07168226Phase 2Not Yet RecruitingPrimary

Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101

NCT04406662RecruitingPrimary

Routine Evaluation of People Living With Cancer

NCT03743064Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT03743051Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT03245658Phase 2Withdrawn

The Effect of Cannabis in Pancreatic Cancer

NCT04131426Phase 1CompletedPrimary

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia

NCT03283488Phase 2CompletedPrimary

Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.

NCT03789136UnknownPrimary

The Effect of Colon Cancer on Muscle Gene Expression, Body Composition, Muscle Function, and Muscle Metabolism

NCT04001010Phase 3Suspended

Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia

NCT04034745Withdrawn

Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain

NCT04353063Not ApplicableUnknownPrimary

Muscle Wasting in Children and Adolescents With Cancer

NCT03316157Not ApplicableCompletedPrimary

Exercise and Nutritional Rehabilitation in Patients With Cancer

NCT04136249Not ApplicableUnknown

Improvement of Neuromuscular Function, Fatigue and Quality of Life by Optimizing Muscle Building and Nutrition in Colorectal Cancer: a Pilot Study

NCT03012139Completed

Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology

NCT04161794Not ApplicableCompletedPrimary

Multimodal Intervention for Patients With Non-small Cell Lung Cancer

NCT03263520Not ApplicableCompletedPrimary

Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer

Scroll to load more

Research Network

Activity Timeline